Want to see CPHI full AI Analyst Report?
China Pharma Holdings (CPHI) Income Statement
293 Followers
China Pharma Holdings Income Statement
Last quarter (Q2 2026), China Pharma Holdings's total revenue was $948.34K, a decrease of 7.55% from the same quarter last year. In Q2, China Pharma Holdings's net income was $-1.46M. See China Pharma Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| $ 4.14M | $ 4.53M | $ 7.01M | $ 8.10M | $ 9.64M | |
| $ -131.95K | $ -1.99M | $ -281.08K | $ -493.92K | $ 349.27K | |
| $ 2.96M | $ 2.60M | $ 2.47M | $ 3.06M | $ 3.21M | |
| Depreciation and Amortization | $ 1.58M | $ 2.62M | $ 2.75M | $ 2.70M | $ 3.09M |
| $ -1.51M | $ -1.96M | $ 8.44K | $ -837.69K | $ 230.34K | |
| $ -3.09M | $ -4.59M | $ -2.75M | $ -3.55M | $ -2.86M | |
| $ -99.02K | $ -147.50K | $ -327.00K | $ -423.86K | $ -538.97K | |
| $ -3.19M | $ -4.74M | $ -3.08M | $ -3.97M | $ -3.40M | |
| $ -3.19M | $ -4.74M | $ -3.08M | $ -3.97M | $ -3.40M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.74 | $ -0.27 | $ -0.29 | $ -1.94 | $ -0.85 |
| Diluted EPS | $ -0.74 | $ -0.27 | $ -0.29 | $ -1.94 | $ -0.85 |
| Weighted Average Shares Outstanding | 4.29M | 17.46M | 10.60M | 5.26M | 4.61M |
| Weighted Average Shares Outstanding (Diluted) | 4.29M | 17.46M | 10.60M | 5.26M | 4.61M |
Currency in USD
